{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:47:55Z","timestamp":1794030475901,"version":"4.8.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32300537"],"award-info":[{"award-number":["32300537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31771479, 81991511, 81991510, 32370593"],"award-info":[{"award-number":["31771479, 81991511, 81991510, 32370593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U21A2084"],"award-info":[{"award-number":["U21A2084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFF1203100"],"award-info":[{"award-number":["2022YFF1203100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2022B1515230005"],"award-info":[{"award-number":["2022B1515230005"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Key Area R&D Program","award":["2024B0101080001"],"award-info":[{"award-number":["2024B0101080001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>NSCLC frequently metastasizes to bone, where the microenvironment becomes immunosuppressive, limiting immunotherapy efficacy. Tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) contribute to immune evasion, but CAF subset origins and roles in bone metastases remain unclear. We investigated whether TAMs undergo macrophage-to-myofibroblast transition (MMT) to generate an immunosuppressive CAF subpopulation in bone lesions, driven by ASCL2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated single-cell RNA sequencing of primary lung tumors and bone metastases with pseudotime and regulon analyses to resolve CAF heterogeneity and nominate MMT regulators. Findings were validated by immunofluorescence and flow cytometry in patient tissues and a murine bone-metastasis model. In vitro, TGF-\u03b21-induced MMT with ASCL2 knockdown\/rescue and T-cell co-culture assays were used to assess CAF_7-like induction and immunosuppressive function. In vivo, macrophage depletion\/reconstitution, donor and endogenous tracing, and macrophage-directed ASCL2 or Il6ra knockdown were performed in a mouse bone-metastasis model to assess CAF_7-like abundance, tumor burden, and T-cell states; ASCL2 inhibition was further evaluated with PD-1 blockade for tumor control and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven CAF subsets were identified, including a bone metastasis\u2013enriched subset (CAF_7) that co-expressed macrophage, MHC-II, and stromal markers. Trajectory analyses, together with the observation that LLC-conditioned medium induced a CAF_7-like shift in bone marrow\u2013derived macrophages in vitro and that both exogenous GFP-labeled BMDMs and endogenous macrophage-lineage-traced cells acquired CAF_7-like features in the bone metastatic microenvironment, supported TAM-to-CAF_7-like transition via MMT. CAF_7 accumulation correlated with increased Treg infiltration, CD8\u207a T cell exhaustion, and poorer survival. Regulon analysis highlighted ASCL2 as a CAF_7-associated regulator; ASCL2 increased in vitro during MMT, and in vivo ASCL2 protein and ASCL2\u207a CAF_7-like cells were enriched in bone-metastasis lesions versus sham marrow or subcutaneous tumors. ASCL2 knockdown in macrophages blocked MMT, reducing CAF_7-like cells and associated Treg and exhausted CD8\u207a T cells, and suppressing tumor growth. Mechanistically, ASCL2 directly transactivated Il6ra, and macrophage Il6ra knockdown phenocopied ASCL2 silencing in vivo. Notably, ASCL2 silencing synergized with anti\u2013PD-1 therapy, improving tumor control and extending survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In NSCLC bone metastases, ASCL2-driven MMT converts TAMs into immunosuppressive CAF_7 that promotes immune escape. Targeting ASCL2 disrupts this transition, restores anti-tumor immunity, and may improve immunotherapy efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03735-1","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:27:09Z","timestamp":1779110829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ASCL2-mediated macrophage-myofibroblast transition generates immunosuppressive CAF_7 in NSCLC bone metastases"],"prefix":"10.1186","volume":"45","author":[{"given":"Jinfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"14","key":"3735_CR1","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.7150\/ijbs.100960","volume":"20","author":"M Xue","year":"2024","unstructured":"Xue M, Ma L, Zhang P, et al. New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies[J]. Int J Biol Sci. 2024;20(14):5747\u201363.","journal-title":"Int J Biol Sci"},{"key":"3735_CR2","doi-asserted-by":"publisher","first-page":"1493773","DOI":"10.3389\/fimmu.2024.1493773","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, She J, Sun R, et al. Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis[J]. Front Immunol. 2024;15:1493773.","journal-title":"Front Immunol"},{"key":"3735_CR3","doi-asserted-by":"crossref","unstructured":"Del Conte A, De Carlo E, Bertoli E et al. Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications[J]. Int J Mol Sci. 2022;23(12):6832.","DOI":"10.3390\/ijms23126832"},{"issue":"8","key":"3735_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","volume":"18","author":"LC Hofbauer","year":"2021","unstructured":"Hofbauer LC, Bozec A, Rauner M, et al. Novel approaches to target the microenvironment of bone metastasis[J]. Nat Rev Clin Oncol. 2021;18(8):488\u2013505.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3735_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s40425-019-0793-8","volume":"7","author":"L Landi","year":"2019","unstructured":"Landi L, D\u2019Inc\u00e0 F, Gelibter A, et al. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer[J]. J Immunother Cancer. 2019;7(1):316.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3735_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives[J]. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"1","key":"3735_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M, Yang Y, Xiong L, et al. Metabolism, metabolites, and macrophages in cancer[J]. J Hematol Oncol. 2023;16(1):80.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3735_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer[J]. Cancer Cell. 2024;42(3):396\u2013412.","journal-title":"Cancer Cell"},{"issue":"1","key":"3735_CR9","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, et al. TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure[J]. Nat Commun. 2018;9(1):4692.","journal-title":"Nat Commun"},{"issue":"1","key":"3735_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance[J]. NPJ Precis Oncol. 2024;8(1):31.","journal-title":"NPJ Precis Oncol"},{"key":"3735_CR11","doi-asserted-by":"publisher","first-page":"115622","DOI":"10.1016\/j.biopha.2023.115622","volume":"167","author":"D Gao","year":"2023","unstructured":"Gao D, Fang L, Liu C, et al. Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells[J]. Biomed Pharmacother. 2023;167:115622.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3735_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-022-03813-w","volume":"20","author":"M Liu","year":"2022","unstructured":"Liu M, Liu L, Song Y, et al. Targeting macrophages: a novel treatment strategy in solid tumors[J]. J Transl Med. 2022;20(1):586.","journal-title":"J Transl Med"},{"key":"3735_CR13","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, et al. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting[J]. Adv Drug Deliv Rev. 2022;189:114504.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"3735_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, et al. Cancer-associated fibroblasts: from basic science to anticancer therapy[J]. Exp Mol Med. 2023;55(7):1322\u201332.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3735_CR15","doi-asserted-by":"publisher","first-page":"e2101235","DOI":"10.1002\/advs.202101235","volume":"9","author":"PC Tang","year":"2022","unstructured":"Tang PC, Chung JY, Xue VW, et al. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition[J]. Adv Sci (Weinh). 2022;9(1):e2101235.","journal-title":"Adv Sci (Weinh)"},{"key":"3735_CR16","doi-asserted-by":"publisher","first-page":"215597","DOI":"10.1016\/j.canlet.2022.215597","volume":"532","author":"M Ito","year":"2022","unstructured":"Ito M, Nakano M, Ariyama H, et al. Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions[J]. Cancer Lett. 2022;532:215597.","journal-title":"Cancer Lett"},{"issue":"11","key":"3735_CR17","doi-asserted-by":"publisher","first-page":"e2412123","DOI":"10.1002\/advs.202412123","volume":"12","author":"Q Yao","year":"2025","unstructured":"Yao Q, Zheng X, Zhang X, et al. METTL3 Potentiates M2 Macrophage-Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF-\u03b21\/Smad3 Pathway[J]. Adv Sci (Weinh). 2025;12(11):e2412123.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"3735_CR18","doi-asserted-by":"publisher","first-page":"e2495","DOI":"10.1038\/cddis.2016.402","volume":"7","author":"X Meng","year":"2016","unstructured":"Meng X, Wang S, Huang X, et al. Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis[J]. Cell Death Dis. 2016;7(12):e2495.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3735_CR19","doi-asserted-by":"publisher","first-page":"e2302203","DOI":"10.1002\/advs.202302203","volume":"11","author":"PC Tang","year":"2024","unstructured":"Tang PC, Chan MK, Chung JY, et al. Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage-Myofibroblast Transition in Non-Small-Cell Lung Carcinoma[J]. Adv Sci (Weinh). 2024;11(1):e2302203.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"3735_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","volume":"40","author":"H Huang","year":"2022","unstructured":"Huang H, Wang Z, Zhang Y, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer[J]. Cancer Cell. 2022;40(6):656\u201373.","journal-title":"Cancer Cell"},{"issue":"1","key":"3735_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-024-00523-y","volume":"8","author":"Y Hu","year":"2024","unstructured":"Hu Y, Recouvreux MS, Haro M, et al. INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer[J]. NPJ Precis Oncol. 2024;8(1):35.","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"3735_CR22","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","volume":"30","author":"J Chen","year":"2022","unstructured":"Chen J, Tang Y, Zhong Y, et al. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition[J]. Mol Ther. 2022;30(9):3017\u201333.","journal-title":"Mol Ther"},{"issue":"40","key":"3735_CR23","doi-asserted-by":"publisher","first-page":"eabn5535","DOI":"10.1126\/sciadv.abn5535","volume":"8","author":"PC Tang","year":"2022","unstructured":"Tang PC, Chung JY, Liao J, et al. Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain[J]. Sci Adv. 2022;8(40):eabn5535.","journal-title":"Sci Adv"},{"key":"3735_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2021.06.030","volume":"520","author":"F Pin","year":"2021","unstructured":"Pin F, Prideaux M, Huot JR, et al. Non-bone metastatic cancers promote osteocyte-induced bone destruction[J]. Cancer Lett. 2021;520:80\u201390.","journal-title":"Cancer Lett"},{"issue":"2","key":"3735_CR25","doi-asserted-by":"publisher","first-page":"103120","DOI":"10.1016\/j.xpro.2024.103120","volume":"5","author":"X Fang","year":"2024","unstructured":"Fang X, Wu Y, Qin H, et al. Protocol for building an in vitro model of M2-like tumor-associated macrophages with lactic acid or conditioned medium from Lewis cells[J]. STAR Protoc. 2024;5(2):103120.","journal-title":"STAR Protoc"},{"issue":"1","key":"3735_CR26","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer[J]. Nat Commun. 2021;12(1):2540.","journal-title":"Nat Commun"},{"issue":"1","key":"3735_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-021-00824-9","volume":"7","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Wang C, et al. Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer[J]. Signal Transduct Target Ther. 2022;7(1):9.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3735_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage[J]. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"1","key":"3735_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat[J]. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"10","key":"3735_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, et al. Reversed graph embedding resolves complex single-cell trajectories[J]. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"issue":"7","key":"3735_CR31","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, Flerin C, Davie K, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis[J]. Nat Protoc. 2020;15(7):2247\u201376.","journal-title":"Nat Protoc"},{"issue":"1","key":"3735_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","volume":"23","author":"Y Liu","year":"2025","unstructured":"Liu Y, Dong G, Yu J, et al. Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential[J]. J Transl Med. 2025;23(1):198.","journal-title":"J Transl Med"},{"issue":"W1","key":"3735_CR33","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis[J]. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3735_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer[J]. Br J Pharmacol. 2024;181(3):362\u201374.","journal-title":"Br J Pharmacol"},{"issue":"22","key":"3735_CR35","doi-asserted-by":"publisher","first-page":"e4231","DOI":"10.21769\/BioProtoc.4231","volume":"11","author":"B Zhang","year":"2021","unstructured":"Zhang B, Li X, Qian W, et al. Measurement of Bone Metastatic Tumor Growth by a Tibial Tumorigenesis Assay[J]. Bio Protoc. 2021;11(22):e4231.","journal-title":"Bio Protoc"},{"issue":"6","key":"3735_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ccell.2025.03.036","volume":"43","author":"J Cheng","year":"2025","unstructured":"Cheng J, Jin Z, Su C, et al. Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts[J]. Cancer Cell. 2025;43(6):1093\u2013107.","journal-title":"Cancer Cell"},{"key":"3735_CR37","doi-asserted-by":"crossref","unstructured":"Xie J, Xu Y, Liu X et al. Mechanically stimulated osteocytes maintain tumor dormancy in bone metastasis of non-small cell lung cancer by releasing small extracellular vesicles[J]. Elife. 2024;12:RP89613.","DOI":"10.7554\/eLife.89613"},{"issue":"1","key":"3735_CR38","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","volume":"14","author":"JY Chung","year":"2023","unstructured":"Chung JY, Tang PC, Chan MK, et al. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma[J]. Nat Commun. 2023;14(1):1794.","journal-title":"Nat Commun"},{"issue":"1","key":"3735_CR39","doi-asserted-by":"publisher","first-page":"2010894","DOI":"10.1080\/2162402X.2021.2010894","volume":"11","author":"L Shao","year":"2022","unstructured":"Shao L, Yu X, Han Q, et al. Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma[J]. Oncoimmunology. 2022;11(1):2010894.","journal-title":"Oncoimmunology"},{"issue":"1","key":"3735_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"G Zhu","year":"2023","unstructured":"Zhu G, Tang Z, Huang R, et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor[J]. Cell Discov. 2023;9(1):25.","journal-title":"Cell Discov"},{"issue":"1","key":"3735_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12967-025-06744-4","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang L, Ma W, et al. Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment[J]. J Transl Med. 2025;23(1):697.","journal-title":"J Transl Med"},{"issue":"9","key":"3735_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression?[J]. Cell Death Dis. 2023;14(9):587.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3735_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","volume":"43","author":"W Yang","year":"2024","unstructured":"Yang W, Liu S, Mao M, et al. T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution[J]. J Exp Clin Cancer Res. 2024;43(1):38.","journal-title":"J Exp Clin Cancer Res"},{"key":"3735_CR44","doi-asserted-by":"publisher","first-page":"216985","DOI":"10.1016\/j.canlet.2024.216985","volume":"595","author":"DJ Agorku","year":"2024","unstructured":"Agorku DJ, Bosio A, Alves F, et al. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling[J]. Cancer Lett. 2024;595:216985.","journal-title":"Cancer Lett"},{"issue":"1","key":"3735_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40364-024-00656-z","volume":"12","author":"J Jiang","year":"2024","unstructured":"Jiang J, Xu C, Han D, et al. Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma[J]. Biomark Res. 2024;12(1):113.","journal-title":"Biomark Res"},{"issue":"2","key":"3735_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccell.2023.12.008","volume":"42","author":"J Wienke","year":"2024","unstructured":"Wienke J, Visser LL, Kholosy WM, et al. Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy[J]. Cancer Cell. 2024;42(2):283\u2013300.","journal-title":"Cancer Cell"},{"issue":"1","key":"3735_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13048-025-01668-5","volume":"18","author":"H Liang","year":"2025","unstructured":"Liang H, Zhang S. Thrombospondin-1 induces CD8(+) T cell exhaustion and immune suppression within the tumor microenvironment of ovarian cancer[J]. J Ovarian Res. 2025;18(1):99.","journal-title":"J Ovarian Res"},{"issue":"1","key":"3735_CR48","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1038\/s41467-025-59529-0","volume":"16","author":"R Trehan","year":"2025","unstructured":"Trehan R, Huang P, Zhu XB, et al. SPP1\u2009+\u2009macrophages cause exhaustion of tumor-specific T cells in liver metastases[J]. Nat Commun. 2025;16(1):4242.","journal-title":"Nat Commun"},{"issue":"8011","key":"3735_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","volume":"629","author":"SB Lacher","year":"2024","unstructured":"Lacher SB, D\u00f6rr J, de Almeida GP, et al. PGE(2) limits effector expansion of tumour-infiltrating stem-like CD8(+) T cells[J]. Nature. 2024;629(8011):417\u201325.","journal-title":"Nature"},{"issue":"1","key":"3735_CR50","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.xcrm.2022.100878","volume":"4","author":"MA Huseni","year":"2023","unstructured":"Huseni MA, Wang L, Klementowicz JE, et al. CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy[J]. Cell Rep Med. 2023;4(1):100878.","journal-title":"Cell Rep Med"},{"issue":"1","key":"3735_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s12276-023-01150-6","volume":"56","author":"E Park","year":"2024","unstructured":"Park E, Lee C. Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies[J]. Exp Mol Med. 2024;56(1):100\u20139.","journal-title":"Exp Mol Med"},{"issue":"9","key":"3735_CR52","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1158\/0008-5472.CAN-16-2446","volume":"77","author":"H Tsukamoto","year":"2017","unstructured":"Tsukamoto H, Fujieda K, Hirayama M, et al. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression[J]. Cancer Res. 2017;77(9):2279\u201391.","journal-title":"Cancer Res"},{"issue":"10","key":"3735_CR53","doi-asserted-by":"publisher","first-page":"a16295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease[J]. Cold Spring Harb Perspect Biol. 2014;6(10):a16295.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"3735_CR54","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T. IL-6: regulator of Treg\/Th17 balance[J]. Eur J Immunol. 2010;40(7):1830\u20135.","journal-title":"Eur J Immunol"},{"issue":"11","key":"3735_CR55","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3[J]. Nat Rev Cancer. 2009;9(11):798\u2013809.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3735_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","volume":"26","author":"DT Fisher","year":"2014","unstructured":"Fisher DT, Appenheimer MM, Evans SS. The two faces of IL-6 in the tumor microenvironment[J]. Semin Immunol. 2014;26(1):38\u201347.","journal-title":"Semin Immunol"},{"key":"3735_CR57","doi-asserted-by":"crossref","unstructured":"Trivedi T, Pagnotti GM, Guise TA et al. The Role of TGF-\u03b2 in Bone Metastases[J]. Biomolecules. 2021;11(11):1643.","DOI":"10.3390\/biom11111643"},{"issue":"11","key":"3735_CR58","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.3961","volume":"21","author":"DL Waning","year":"2015","unstructured":"Waning DL, Mohammad KS, Reiken S, et al. Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice[J]. Nat Med. 2015;21(11):1262\u201371.","journal-title":"Nat Med"},{"key":"3735_CR59","doi-asserted-by":"crossref","unstructured":"Ben-Ghedalia-Peled N, Vago R. Wnt Signaling in the Development of Bone Metastasis[J]. Cells. 2022;11(23):3934.","DOI":"10.3390\/cells11233934"},{"key":"3735_CR60","doi-asserted-by":"crossref","unstructured":"Nolan E, Kang Y, Malanchi I. Mechanisms of Organ-Specific Metastasis of Breast Cancer[J]. Cold Spring Harb Perspect Med. 2023;13(11):a041326.","DOI":"10.1101\/cshperspect.a041326"},{"issue":"2","key":"3735_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.stem.2014.12.006","volume":"16","author":"J Schuijers","year":"2015","unstructured":"Schuijers J, Junker JP, Mokry M, et al. Ascl2 acts as an R-spondin\/Wnt-responsive switch to control stemness in intestinal crypts[J]. Cell Stem Cell. 2015;16(2):158\u201370.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3735_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy[J]. Signal Transduct Target Ther. 2024;9(1):266.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3735_CR63","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1002\/ctm2.1605","volume":"14","author":"K Xu","year":"2024","unstructured":"Xu K, Wang H, Zou Y, et al. Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer[J]. Clin Transl Med. 2024;14(3):e1605.","journal-title":"Clin Transl Med"},{"issue":"5955","key":"3735_CR64","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry A, Rudra D, Treuting P, et al. CD4\u2009+\u2009regulatory T cells control TH17 responses in a Stat3-dependent manner[J]. Science. 2009;326(5955):986\u201391.","journal-title":"Science"},{"issue":"9","key":"3735_CR65","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6[J]. Int J Biol Sci. 2012;8(9):1237\u201347.","journal-title":"Int J Biol Sci"},{"key":"3735_CR66","doi-asserted-by":"publisher","first-page":"1335366","DOI":"10.3389\/fimmu.2024.1335366","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Lei J, Mou H, et al. Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors[J]. Front Immunol. 2024;15:1335366.","journal-title":"Front Immunol"},{"issue":"2","key":"3735_CR67","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4161\/onci.1.2.18480","volume":"1","author":"E Zhao","year":"2012","unstructured":"Zhao E, Wang L, Dai J, et al. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer[J]. Oncoimmunology. 2012;1(2):152\u201361.","journal-title":"Oncoimmunology"},{"issue":"8","key":"3735_CR68","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts[J]. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"key":"3735_CR69","doi-asserted-by":"crossref","unstructured":"Kerdidani D, Aerakis E, Verrou K et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts[J]. J Exp Med. 2022;219(2):e20210815.","DOI":"10.1084\/jem.20210815"},{"issue":"12","key":"3735_CR70","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.ccell.2025.09.001","volume":"43","author":"X Chen","year":"2025","unstructured":"Chen X, Zhou Z, Xie L, et al. Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches[J]. Cancer Cell. 2025;43(12):2224\u201340.","journal-title":"Cancer Cell"},{"issue":"1","key":"3735_CR71","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer[J]. Nat Commun. 2022;13(1):1742.","journal-title":"Nat Commun"},{"issue":"7","key":"3735_CR72","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.21037\/tlcr-2025-244","volume":"14","author":"M Xiao","year":"2025","unstructured":"Xiao M, Deng Y, Guo H, et al. Single-cell and spatial transcriptomics profile the interaction of SPP1(+) macrophages and FAP(+) fibroblasts in non-small cell lung cancer[J]. Transl Lung Cancer Res. 2025;14(7):2646\u201369.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"3735_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z, Quazi S, Arora S, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects[J]. J Biomed Sci. 2025;32(1):7.","journal-title":"J Biomed Sci"},{"issue":"1","key":"3735_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy[J]. J Hematol Oncol. 2019;12(1):86.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3735_CR75","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1038\/s41467-022-32782-3","volume":"13","author":"EI Rivas","year":"2022","unstructured":"Rivas EI, Linares J, Zwick M, et al. Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2\u2009+\u2009breast tumors[J]. Nat Commun. 2022;13(1):5310.","journal-title":"Nat Commun"},{"issue":"1","key":"3735_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives[J]. Signal Transduct Target Ther. 2024;9(1):192.","journal-title":"Signal Transduct Target Ther"},{"issue":"9617","key":"3735_CR77","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen JS, Beaulieu A, Rubbert-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial[J]. Lancet. 2008;371(9617):987\u201397.","journal-title":"Lancet"},{"issue":"D1","key":"3735_CR78","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics[J]. Nucleic Acids Res. 2025;53(D1):D1670\u20136.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03735-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03735-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03735-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:44:35Z","timestamp":1782985475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03735-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03735-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human sample collection and animal experiments were approved by the Ethics Committee of Guangdong Provincial People\u2019s Hospital (KY2025-741-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}